Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2021

10.02.2020 | Original Article

Quality of Care Among Medicare Patients Undergoing Pancreatic Surgery: Safety Grade, Magnet Recognition, and Leapfrog Minimum Volume Standards—Which Quality Benchmark Matters?

verfasst von: Katiuscha Merath, Rittal Mehta, Diamantis I. Tsilimigras, Ayesha Farooq, Kota Sahara, Anghela Z. Paredes, Lu Wu, Amika Moro, Aslam Ejaz, Mary Dillhoff, Jordan Cloyd, Allan Tsung, Timothy M. Pawlik

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

The association of national quality benchmarking metrics with postoperative outcomes following complex surgery remains unknown. We assessed the relationship between the “quality trifactor” of Leapfrog minimum volume standards, Hospital Safety Grade A, and Magnet Recognition with outcomes of Medicare patients undergoing pancreatectomy.

Methods

The Standard Analytic Files (SAF) merged with Leapfrog Hospital Survey and Leapfrog Safety Scores Denominator Files were reviewed to identify Medicare patients who underwent pancreatic procedures between 2013 and 2015. Primary outcomes were overall and serious complications, as well as 30- and 90-day mortality. Multivariable logistic regression analyses were conducted to evaluate possible associations among hospitals meeting the quality trifactor and short-term outcomes.

Results

Among 4853 Medicare patients, 909 (18.7%) underwent pancreatectomy at hospitals meeting the quality trifactor. Among 260 hospitals, 7.3% (n = 19) met the quality trifactor. Safety Grade A (48.8%, n = 127) was the most commonly met criterion followed by Magnet Recognition (36.2%, n = 94); the Leapfrog minimum volume standards were achieved by 25% (n = 65) of hospitals. Patients undergoing surgery at hospitals that were only Safety Grade A and Magnet designated, but did not meet Leapfrog criteria, had higher odds of serious complications (OR 1.59, 95% CI 1.00–2.51). In contrast, patients undergoing treatment at hospitals having all three designations (i.e., the quality trifactor) had 40% and 39% lower odds of both serious complications (OR 0.60, 95% CI 0.37–0.97) and 90-day mortality (OR 0.61, 95% CI 0.42–0.89), respectively. In turn, patients undergoing pancreatectomy at quality trifactor hospitals had higher odds of experiencing the composite quality measure textbook outcome (OR 1.28, 95% CI 1.03–1.59) versus patients undergoing pancreatectomy at non-trifactor hospitals.

Conclusion

While Safety Grade A and Magnet designation alone were not associated with higher odds of an optimal composite outcome following pancreatectomy, compliance with Leapfrog criteria to achieve the “quality trifactor” metric was associated with lower odds of serious complications and mortality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Merkow RP, Chung JW, Paruch JL, Bentrem DJ, Bilimoria KY. Relationship between cancer center accreditation and performance on publicly reported quality measures. Ann Surg. 2014;259(6):1091–1097.CrossRef Merkow RP, Chung JW, Paruch JL, Bentrem DJ, Bilimoria KY. Relationship between cancer center accreditation and performance on publicly reported quality measures. Ann Surg. 2014;259(6):1091–1097.CrossRef
3.
Zurück zum Zitat Schmaltz SP, Williams SC, Chassin MR, Loeb JM, Wachter RM. Hospital performance trends on national quality measures and the association with Joint Commission accreditation. J Hosp Med. 2011;6(8):454–461.CrossRef Schmaltz SP, Williams SC, Chassin MR, Loeb JM, Wachter RM. Hospital performance trends on national quality measures and the association with Joint Commission accreditation. J Hosp Med. 2011;6(8):454–461.CrossRef
4.
Zurück zum Zitat Chen J, Rathore SS, Radford MJ, Krumholz HM. JCAHO accreditation and quality of care for acute myocardial infarction. Health Aff (Millwood). 2003;22(2):243–254.CrossRef Chen J, Rathore SS, Radford MJ, Krumholz HM. JCAHO accreditation and quality of care for acute myocardial infarction. Health Aff (Millwood). 2003;22(2):243–254.CrossRef
5.
Zurück zum Zitat Knutson AC, McNamara EJ, McKellar DP, Kaufman CS, Winchester DP. The role of the American College of Surgeons’ cancer program accreditation in influencing oncologic outcomes. J Surg Oncol. 2014;110(5):611–615.CrossRef Knutson AC, McNamara EJ, McKellar DP, Kaufman CS, Winchester DP. The role of the American College of Surgeons’ cancer program accreditation in influencing oncologic outcomes. J Surg Oncol. 2014;110(5):611–615.CrossRef
6.
Zurück zum Zitat Galvin RS, Delbanco S, Milstein A, Belden G. Has the Leapfrog Group had an impact on the health care market? Health Aff (Millwood). 2005;24(1):228–233.CrossRef Galvin RS, Delbanco S, Milstein A, Belden G. Has the Leapfrog Group had an impact on the health care market? Health Aff (Millwood). 2005;24(1):228–233.CrossRef
8.
Zurück zum Zitat Friese CR, Xia R, Ghaferi A, Birkmeyer JD, Banerjee M. Hospitals in ‘Magnet’ program show better patient outcomes on mortality measures compared to non-‘Magnet’ hospitals. Health Aff (Millwood). 2015;34(6):986–992.CrossRef Friese CR, Xia R, Ghaferi A, Birkmeyer JD, Banerjee M. Hospitals in ‘Magnet’ program show better patient outcomes on mortality measures compared to non-‘Magnet’ hospitals. Health Aff (Millwood). 2015;34(6):986–992.CrossRef
9.
Zurück zum Zitat McHugh MD, Kelly LA, Smith HL, Wu ES, Vanak JM, Aiken LH. Lower mortality in magnet hospitals. Med Care. 2013;51(5):382–388.CrossRef McHugh MD, Kelly LA, Smith HL, Wu ES, Vanak JM, Aiken LH. Lower mortality in magnet hospitals. Med Care. 2013;51(5):382–388.CrossRef
10.
Zurück zum Zitat Idrees JJ, Johnston FM, Canner JK, et al. Cost of major complications after liver resection in the United States: are high-volume centers cost-effective? Ann Surg. 2019;269(3):503–510.CrossRef Idrees JJ, Johnston FM, Canner JK, et al. Cost of major complications after liver resection in the United States: are high-volume centers cost-effective? Ann Surg. 2019;269(3):503–510.CrossRef
11.
Zurück zum Zitat Gonzalez AA, Ghaferi AA. Hospital Safety Scores: do grades really matter? JAMA Surg. 2014;149(5):413–414.CrossRef Gonzalez AA, Ghaferi AA. Hospital Safety Scores: do grades really matter? JAMA Surg. 2014;149(5):413–414.CrossRef
12.
Zurück zum Zitat Kernisan LP, Lee SJ, Boscardin WJ, Landefeld CS, Dudley RA. Association between hospital-reported Leapfrog Safe Practices Scores and inpatient mortality. JAMA. 2009;301(13):1341–1348.CrossRef Kernisan LP, Lee SJ, Boscardin WJ, Landefeld CS, Dudley RA. Association between hospital-reported Leapfrog Safe Practices Scores and inpatient mortality. JAMA. 2009;301(13):1341–1348.CrossRef
13.
Zurück zum Zitat Merath K, Chen Q, Bagante F, et al. Textbook outcomes among Medicare patients undergoing hepatopancreatic surgery. Ann Surg. 2018. Merath K, Chen Q, Bagante F, et al. Textbook outcomes among Medicare patients undergoing hepatopancreatic surgery. Ann Surg. 2018.
14.
Zurück zum Zitat Merath K, Chen Q, Bagante F, et al. A multi-institutional international analysis of textbook outcomes among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma. JAMA Surg. 2019:e190571. Merath K, Chen Q, Bagante F, et al. A multi-institutional international analysis of textbook outcomes among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma. JAMA Surg. 2019:e190571.
15.
Zurück zum Zitat Kolfschoten NE, Kievit J, Gooiker GA, et al. Focusing on desired outcomes of care after colon cancer resections; hospital variations in ‘textbook outcome’. Eur J Surg Oncol. 2013;39(2):156–163.CrossRef Kolfschoten NE, Kievit J, Gooiker GA, et al. Focusing on desired outcomes of care after colon cancer resections; hospital variations in ‘textbook outcome’. Eur J Surg Oncol. 2013;39(2):156–163.CrossRef
16.
Zurück zum Zitat Osborne NH, Nicholas LH, Ryan AM, Thumma JR, Dimick JB. Association of hospital participation in a quality reporting program with surgical outcomes and expenditures for Medicare beneficiaries. JAMA. 2015;313(5):496–504.CrossRef Osborne NH, Nicholas LH, Ryan AM, Thumma JR, Dimick JB. Association of hospital participation in a quality reporting program with surgical outcomes and expenditures for Medicare beneficiaries. JAMA. 2015;313(5):496–504.CrossRef
17.
Zurück zum Zitat Iezzoni LI, Daley J, Heeren T, et al. Using administrative data to screen hospitals for high complication rates. Inquiry. 1994;31(1):40–55.PubMed Iezzoni LI, Daley J, Heeren T, et al. Using administrative data to screen hospitals for high complication rates. Inquiry. 1994;31(1):40–55.PubMed
18.
Zurück zum Zitat Mehta R, Ejaz A, Hyer JM, et al. The impact of dedicated cancer centers on outcomes among Medicare beneficiaries undergoing liver and pancreatic cancer surgery. Ann Surg Oncol. 2019. Mehta R, Ejaz A, Hyer JM, et al. The impact of dedicated cancer centers on outcomes among Medicare beneficiaries undergoing liver and pancreatic cancer surgery. Ann Surg Oncol. 2019.
19.
Zurück zum Zitat Ghaferi AA, Osborne NH, Birkmeyer JD, Dimick JB. Hospital characteristics associated with failure to rescue from complications after pancreatectomy. J Am Coll Surg. 2010;211(3):325–330.CrossRef Ghaferi AA, Osborne NH, Birkmeyer JD, Dimick JB. Hospital characteristics associated with failure to rescue from complications after pancreatectomy. J Am Coll Surg. 2010;211(3):325–330.CrossRef
20.
Zurück zum Zitat Chen Q, Merath K, Olsen G, et al. Impact of post-discharge disposition on risk and causes of readmission following liver and pancreas surgery. J Gastrointest Surg. 2018. Chen Q, Merath K, Olsen G, et al. Impact of post-discharge disposition on risk and causes of readmission following liver and pancreas surgery. J Gastrointest Surg. 2018.
21.
Zurück zum Zitat Mise Y, Day RW, Vauthey JN, et al. After pancreatectomy, the “90 days from surgery” definition is superior to the “30 days from discharge” definition for capture of clinically relevant readmissions. J Gastrointest Surg. 2016;20(1):77–84; discussion 84.CrossRef Mise Y, Day RW, Vauthey JN, et al. After pancreatectomy, the “90 days from surgery” definition is superior to the “30 days from discharge” definition for capture of clinically relevant readmissions. J Gastrointest Surg. 2016;20(1):77–84; discussion 84.CrossRef
22.
Zurück zum Zitat Mayo SC, Shore AD, Nathan H, et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011;13(7):473–482.CrossRef Mayo SC, Shore AD, Nathan H, et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011;13(7):473–482.CrossRef
23.
Zurück zum Zitat Duke CC, Smith B, Lynch W, Slover M. The effects of hospital safety scores, total price, out-of-pocket cost, and household income on consumers’ self-reported choice of hospitals. J Patient Saf. 2017;13(4):192–198.CrossRef Duke CC, Smith B, Lynch W, Slover M. The effects of hospital safety scores, total price, out-of-pocket cost, and household income on consumers’ self-reported choice of hospitals. J Patient Saf. 2017;13(4):192–198.CrossRef
25.
Zurück zum Zitat Qian F, Lustik SJ, Diachun CA, Wissler RN, Zollo RA, Glance LG. Association between Leapfrog safe practices score and hospital mortality in major surgery. Med Care. 2011;49(12):1082–1088.PubMed Qian F, Lustik SJ, Diachun CA, Wissler RN, Zollo RA, Glance LG. Association between Leapfrog safe practices score and hospital mortality in major surgery. Med Care. 2011;49(12):1082–1088.PubMed
26.
Zurück zum Zitat Smith SN, Reichert HA, Ameling JM, Meddings J. Dissecting Leapfrog: how well do Leapfrog Safe Practices Scores correlate with hospital compare ratings and penalties, and how much do they matter? Med Care. 2017;55(6):606–614.CrossRef Smith SN, Reichert HA, Ameling JM, Meddings J. Dissecting Leapfrog: how well do Leapfrog Safe Practices Scores correlate with hospital compare ratings and penalties, and how much do they matter? Med Care. 2017;55(6):606–614.CrossRef
27.
Zurück zum Zitat Hwang W, Derk J, LaClair M, Paz H. Hospital patient safety grades may misrepresent hospital performance. J Hosp Med. 2014;9(2):111–115.CrossRef Hwang W, Derk J, LaClair M, Paz H. Hospital patient safety grades may misrepresent hospital performance. J Hosp Med. 2014;9(2):111–115.CrossRef
28.
Zurück zum Zitat Goode CJ, Blegen MA, Park SH, Vaughn T, Spetz J. Comparison of patient outcomes in Magnet® and non-Magnet hospitals. J Nurs Adm. 2011;41(12):517–523.CrossRef Goode CJ, Blegen MA, Park SH, Vaughn T, Spetz J. Comparison of patient outcomes in Magnet® and non-Magnet hospitals. J Nurs Adm. 2011;41(12):517–523.CrossRef
29.
Zurück zum Zitat Mills AC, Gillespie KN. Effect of Magnet hospital recognition on 2 patient outcomes. J Nurs Care Qual. 2013;28(1):17–23.CrossRef Mills AC, Gillespie KN. Effect of Magnet hospital recognition on 2 patient outcomes. J Nurs Care Qual. 2013;28(1):17–23.CrossRef
30.
Zurück zum Zitat Kutney-Lee A, Stimpfel AW, Sloane DM, Cimiotti JP, Quinn LW, Aiken LH. Changes in patient and nurse outcomes associated with magnet hospital recognition. Med Care. 2015;53(6):550–557.CrossRef Kutney-Lee A, Stimpfel AW, Sloane DM, Cimiotti JP, Quinn LW, Aiken LH. Changes in patient and nurse outcomes associated with magnet hospital recognition. Med Care. 2015;53(6):550–557.CrossRef
31.
Zurück zum Zitat Reames BN, Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and operative mortality in the modern era. Ann Surg. 2014;260(2):244–251.CrossRef Reames BN, Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and operative mortality in the modern era. Ann Surg. 2014;260(2):244–251.CrossRef
32.
Zurück zum Zitat Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228(3):429–438.CrossRef Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228(3):429–438.CrossRef
33.
Zurück zum Zitat Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232(6):786–795.CrossRef Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232(6):786–795.CrossRef
34.
Zurück zum Zitat Hyder O, Dodson RM, Nathan H, et al. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surg. 2013;148(12):1095–1102.CrossRef Hyder O, Dodson RM, Nathan H, et al. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surg. 2013;148(12):1095–1102.CrossRef
35.
Zurück zum Zitat Hata T, Motoi F, Ishida M, et al. Effect of hospital volume on surgical outcomes after pancreaticoduodenectomy: a systematic review and meta-analysis. Ann Surg. 2016;263(4):664–672.CrossRef Hata T, Motoi F, Ishida M, et al. Effect of hospital volume on surgical outcomes after pancreaticoduodenectomy: a systematic review and meta-analysis. Ann Surg. 2016;263(4):664–672.CrossRef
36.
Zurück zum Zitat Idrees JJ, Merath K, Gani F, et al. Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma. HPB (Oxford). 2019;21(8):981–989.CrossRef Idrees JJ, Merath K, Gani F, et al. Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma. HPB (Oxford). 2019;21(8):981–989.CrossRef
37.
Zurück zum Zitat Diaz A, Schoenbrunner A, Cloyd J, Pawlik TM. Geographic distribution of adult inpatient surgery capability in the USA. J Gastrointest Surg. 2019. Diaz A, Schoenbrunner A, Cloyd J, Pawlik TM. Geographic distribution of adult inpatient surgery capability in the USA. J Gastrointest Surg. 2019.
Metadaten
Titel
Quality of Care Among Medicare Patients Undergoing Pancreatic Surgery: Safety Grade, Magnet Recognition, and Leapfrog Minimum Volume Standards—Which Quality Benchmark Matters?
verfasst von
Katiuscha Merath
Rittal Mehta
Diamantis I. Tsilimigras
Ayesha Farooq
Kota Sahara
Anghela Z. Paredes
Lu Wu
Amika Moro
Aslam Ejaz
Mary Dillhoff
Jordan Cloyd
Allan Tsung
Timothy M. Pawlik
Publikationsdatum
10.02.2020
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2021
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-019-04504-6

Weitere Artikel der Ausgabe 1/2021

Journal of Gastrointestinal Surgery 1/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.